What is Prostate Progress?

Who can take part and how to become a volunteer

A welcome message from supporter Stephen Fry

How do I join Prostate Progress?

Prostate Progress: Webinar Series

Webinar 1: An Introduction to Prostate Progress

Prostate Progress: Webinar Series

Webinar 2: Benefits and Risks of Participating

Hear from patients about why they joined Prostate Progress and why others should too

Prostate Progress is proud to be the first ‘driver project’ for NHS England’s Data for Research and Development programme. Prostate Progress is powered by NHS Data.



Who funds Prostate Progress?

Prostate Progress is funded by Prostate Cancer Research, sponsorship from the Life Sciences industry, charity partners, trusts and foundations and members of the public via donations.

As part of our ‘Design and Initiation’ phase we received sponsorship from Bayer and Advanced Accelerator Applications (A Novartis Company), as well as in-kind sponsorship from IQVIA.

We will always be open about who funds Prostate Progress.

We will also include a public register on our website of all approved research studies so that participants, the wider public, researchers and policymakers can see how Prostate Progress resources are being used and what studies are being carried out.

Who has reviewed and approved Prostate Progress?

Prostate Progress has been reviewed and approved by the Newcastle & North Tyneside 1 Research Ethics Committee.

Participant Information Sheet

Click on the image to open the Participant Information Sheet

Steering Committee

A big thank you to Prostate Progress' Steering Committee (listed below) as well as the many expert and special advisors and dozens of patients who have contributed to this process.

Rakesh Heer Chair of Urology at Imperial College London
Linda Sharples Professor of Medical Statistics at the London School of Hygiene & Tropical Medicine
Dan Brewer Professor in Medical Bioinformatics and Genomics at University of East Anglia
Ann-Marie Mallon Programme Lead for Research Data Team – The Alan Turing Institute
James Peach CEO of Human-Centric Drug Discovery
Janine De Beer Therapy Area Head Oncology at Bayer
Fraser Chadwick Clinical Research Manager at Bayer
Oliver Wong Medical Manager at Advanced Accelerator Applications (A Novartis Company)
Rebecca Cosgriff Head of Strategy: Data for R&D | NHS Transformation Directorate at NHS England
Patient Representative From Patient Panel
Patient Representative From Patient Panel
Patient Representative From Patient Panel
Press enter or esc to cancel